HiArc - Electronic Health Record
HiArc EHR has been designed to help medical providers save patient information in a more systematic way. The innovative features of HiArc help the provider in improving not only their efficiency but also quality of care. It indeed helps in saving your time and money.
DRUMMOND GROUP’S ONC-ATCB (Office of the National Coordinator for Health Information Technology-Authorized testing and Certification Body) certified HiArc EHR (Version 1.01.00) as complete EHR for stage 1 meaningful use on 10/25/2012, with registration number 10252012-1543-5. HiArc EHR provides you with Stage1 meaningful use criteria for the year 2011-2012. The certification of HiArc EHR ensures it’s users that it meets all the criteria required for the stage1 meaningful use.
The certified General criteria of HiArc EHR are as follows:
Drug-drug, drug-allergy interaction checks.
Drug formulary checks
Maintain up-to-date problem list
Maintain active medication list
Maintain active medication allergy list
Record and chart vital signs
Smoking status
Incorporate laboratory test results
General patient list
Medication reconciliation
Submission to immunization registries
Public health surveillance
Patient specific education resources
Automated measure calculation
Access control
Emergency access
Automatic log-off
Audit log
Integrity
Authentication
General encryption
Encryption when exchanging electronic information
Accounting of disclosures (optional)
The ceritified Ambulatory Criteria for HiArc EHR are as follows:
Computerized provider order entry
Electronic prescribing
Record demographics Patient reminders
Clinical decision support
Electronic copy of health information
Timely access
Clinical summaries
Exchange clinical information and patient summary record
Calculate and submit clinical quality measures
The certified Ambulatory Clinical Quality Measures for HiArc EHR are as follows:
Asthma Assesment
Pharyngitis- Children
Alcohol and Drug Dependence
Prenatal Care: HIV Screening
Hypertension: Blood Pressure Measurement
Prenatal Care: Anti-D immune Globulin
Controlling High Blood Pressure
Youth Weight Assesment
Tobacco Use Cessation
Tobacco Use Assesment and Cessation
Breast Cancer Screening
Cervical Cancer Screening
Chlamydia Screening for Women
Colorectal Cancer Screening
Appropriate Medications for Asthma
Childhood Immunization Status
Influenza Immunization
Pneumonia Vaccination
Asthma Pharmacologic Therapy
Use of Imaging Study: Low Back Pain
Diabetes: Eye Exam
Diabetes: Foot Exam
Diabetes Control: Hemoglobin A1c >9.0%
Diabetic Patients who elevated mmhg V140/90
Nephropathy Screening- Urine
Diabetes Control: LDL < 100mg/dl
Antiplatelet Therapy
Ischemic Vascular Disease: Asparin or other Antithrombotic
Coronoary Artery Disease: Beta Blocker Therapy Post Myocadial Infarction
Blood Pressure Management: Ischemic Valve Disease
Corinary Artery Disease: Lipid Lowering Therapy
IVD: Complete Lipid Panel and LDL Control
Heart Failure: ACE/ ARB Therapy For LVSD (LVEF <40%)
Heart Failure: Beta Blocker for LVSD
Heart Failure: Warfarin Therapy
Primary Open Angle Glaucoma
Diabetic Retinopathy: Macular Edema
Diabetes Management: Retinopathy Screening
Depression Management
Colon Cancer: Chemotherapy
Breast Cancer: Hormonal Therapy
Prostate Cancer: Avoid overuse of Bone Scan
Adult Weight Screening
Diabetes Control: Hemoglobin A1c <8.0%